AEHR TEST SYSTEMS
Aehr Test Systems designs, manufactures and markets semiconductor test, burn-in and reliability-screening equipment for semiconductor manufacturers, contract assemblers, electronics manufacturers, and test and burn-in service companies. Headquartered in Fremont, California, it sells worldwide and provides installation, repair, engineering support, spare parts, training and service contracts. Its wafer- and die-level portfolio includes FOX-XP, FOX-NP and FOX-CP systems, along with WaferPak Contactors, WaferPak Aligners, DiePak Carriers and DiePak Loaders. Package-level products include the Sonoma, Tahoe and Echo burn-in systems. Aehr Test earns money from sales of systems, test fixtures, contactors, carriers, accessories and related services. Its equipment tests and burns in semiconductor wafers, singulated die, modules and packaged devices, including logic, memory, power and photonic devices.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AEHR in the last 30 days.
See all $AEHR insider activity →Aehr Test Systems reported 3Q 2026 revenue of $33.01M, up 200.9% YoY, driven by AI-market demand. Net income was $7.18M, up from a loss a year earlier. Gross margin improved to 47.5% due to higher volume and favorable product mix. Asia and U.S. revenue grew significantly, while Europe and Middle East revenue declined.
Aehr Test Systems reported 201% YoY revenue growth to $33.0M, driven by AI demand, and returned to profitability with a 47.5% gross margin. Key risks include shipment timing, customer concentration, tariffs, and patent litigation. The company had $105.1M in cash at quarter-end.
Aehr Test Systems' average stock price target was reduced from $127.83 to $127 by 5 analysts, with a range of $110 to $140. This implies a 95% upside from the Nov. 3 closing price. The consensus rating remains 'Buy' among 6 analysts.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning AEHR (AEHR TEST SYSTEMS). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent AEHR coverage spans earnings, financial news and corporate actions.
Earnings beat and strong AI demand likely drive buying pressure.
Positive earnings surprise likely to lift the stock.
The slight target reduction may temper bullish sentiment but the implied 95% upside still suggests buying interest.
Target cut suggests reduced upside expectations.
Guidance raise and strong growth may lift the stock.
AlphAI scores every news story that mentions AEHR with an AI model for sentiment and relevance, and aggregates insider trades from AEHR TEST SYSTEMS's SEC EDGAR Form 4 filings. Figures refresh continuously.
Aehr Test Systems reported 3Q 2026 revenue of $33.01M, up 200.9% YoY, driven by AI-market demand. Net income was $7.18M, up from a loss a year earlier. Gross margin improved to 47.5% due to higher volume and favorable product mix. Asia and U.S. revenue grew significantly, while Europe and Middle East revenue declined.
Aehr Test Systems reported 201% YoY revenue growth to $33.0M, driven by AI demand, and returned to profitability with a 47.5% gross margin. Key risks include shipment timing, customer concentration, tariffs, and patent litigation. The company had $105.1M in cash at quarter-end.
Aehr Test Systems' average stock price target was reduced from $127.83 to $127 by 5 analysts, with a range of $110 to $140. This implies a 95% upside from the Nov. 3 closing price. The consensus rating remains 'Buy' among 6 analysts.
Jefferies kept Aehr Test System's rating at Buy but reduced its price target from $175 to $140, a 20% decrease. This new target suggests a 172% upside from the stock's Nov 2 close of $51.47, according to the firm.
Aehr Test Systems reported record Q1 2027 revenue of $33M, up 200% YoY, with $46.7M in bookings. It raised its fiscal-year outlook to $150M. A major chip supplier plans to evaluate its FOX-XP test cell in Taiwan. The company has over a dozen potential customers. Cash reserves were $105.1M as of September 25, 2026.
Aehr Test Systems reported record Q1 fiscal 2027 revenue of $33.0M, up 200% YoY, and raised its fiscal 2027 revenue outlook to $150M. GAAP net income was $7.2M, with non-GAAP EPS of $0.28. The company cited strong demand for its FOX and Sonoma solutions, with significant orders from AI and hyperscale customers.
AEHR TEST SYSTEMS (AEHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Contacts: Aehr Test Systems PondelWilkinson Chris Siu Todd Kehrli Chief Financial Officer Investor Contact csiu@aehr.com tkehrli@pondel.com Aehr Test Systems Reports Record First Quarter Fiscal 2027 Revenue of $33.0 Million; Raises Full-Year Revenue Outlook to $150 M
AEHR TEST SYSTEMS (AEHR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Narsing Vijayrao to the Board of Directors On October 24, 2026, the Board of Directors (the “Board”) of Aeh
Aehr Test Systems (AEHR) added Vijay Rao, ex-Meta VP of Infrastructure, to its board, effective Oct. 28, 2026. The move aims to enhance credibility in AI and data center testing.
AEHR TEST SYSTEMS (AEHR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. The Annual Meeting of shareholders of Aehr Test Systems (the “Company”) was held on October 19, 2026 (the “Annual Meeting”). There were 32,659,546 shares of common stock entitled to vote at the Annual Meeting and 22,
